In perspective: CSL112 (apolipoprotein A-I) infusions and cardiovascular outcomes in patients with acute myocardial infarction: the ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II) trial

Frederik H Verbrugge, Konstantin A Krychtiuk

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)362-364
Number of pages3
JournalEuropean Heart Journal. Acute Cardiovascular Care
Volume13
Issue number4
DOIs
Publication statusPublished - 1 Apr 2024

Keywords

  • Humans
  • Myocardial Infarction
  • Apolipoprotein A-I/administration & dosage
  • Infusions, Intravenous
  • Treatment Outcome

Cite this